Evidence map›Paper›PMID 34879820›Full record

Trial reportBMC infectious diseases2021

Identifying youth at high risk for sexually transmitted infections in community-based settings using a risk prediction tool: a validation study.

Katharina Kranzer, Victoria Simms, Ethel Dauya, Ioana D Olaru, Chido Dziva Chikwari, Kevin Martin, Nicol Redzo, Tsitsi Bandason, Mandikudza Tembo, Suzanna C Francis and 7 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Katharina KranzerClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. katharina.kranzer@lshtm.ac.uk.
Victoria SimmsBiomedical Research and Training Institute, Harare, Zimbabwe.
Ethel DauyaBiomedical Research and Training Institute, Harare, Zimbabwe.
Ioana D OlaruClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Chido Dziva ChikwariClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Kevin MartinClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Nicol RedzoBiomedical Research and Training Institute, Harare, Zimbabwe.
Tsitsi BandasonBiomedical Research and Training Institute, Harare, Zimbabwe.
Mandikudza TemboBiomedical Research and Training Institute, Harare, Zimbabwe.
Suzanna C FrancisMRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Helen A WeissMRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Richard J HayesMRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Constancia MavodzaBiomedical Research and Training Institute, Harare, Zimbabwe.
Tsitsi ApolloAIDS and TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.
Gertrude NcubeAIDS and TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.
Anna MachihaAIDS and TB Unit, Ministry of Health and Child Care, Harare, Zimbabwe.
Rashida Abbas FerrandClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Biomedical Research and Training Institute · ZWLondon School of Hygiene & Tropical Medicine · GBMinistry of Health and Child Welfare · ZWBrighton and Sussex Medical School · GB

Funding

Medical Research Council MR/R010161/1Medical Research Council MR/T040327/1Wellcome Trust 206316/Z/17/ZWellcome Trust 206316_Z_17_Z
6 · The paper itself

Abstract

backgroundChlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are the most common bacterial sexually transmitted infections (STIs) worldwide. In the absence of affordable point-of-care STI tests, WHO recommends STI testing based on risk factors. This study aimed to develop a prediction tool with a sensitivity of > 90% and efficiency (defined as the percentage of individuals that are eligible for diagnostic testing) of < 60%.

methodsThis study offered CT/NG testing as part of a cluster-randomised trial of community-based delivery of sexual and reproductive health services to youth aged 16-24 years in Zimbabwe. All individuals accepting STI testing completed an STI risk factor questionnaire. The outcome was positivity for either CT or NG. Backwards-stepwise logistic regression was performed with p ≥ 0.05 as criteria for exclusion. Coefficients of variables included in the final multivariable model were multiplied by 10 to generate weights for a STI risk prediction tool. A maximum likelihood Receiver Operating Characteristics (ROC) model was fitted, with the continuous variable score divided into 15 categories of equal size. Sensitivity, efficiency and number needed to screen were calculated for different cut-points.

resultsFrom 3 December 2019 to 5 February 2020, 1007 individuals opted for STI testing, of whom 1003 (99.6%) completed the questionnaire. CT/NG prevalence was 17.5% (95% CI 15.1, 19.8) (n = 175). CT/NG positivity was independently associated with being female, number of lifetime sexual partners, relationship status, HIV status, self-assessed STI risk and past or current pregnancy. The STI risk prediction score including those variables ranged from 2 to 46 with an area under the ROC curve of 0.72 (95% CI 0.68, 0.76). Two cut-points were chosen: (i) 23 for optimised sensitivity (75.9%) and specificity (59.3%) and (ii) 19 to maximise sensitivity (82.4%) while keeping efficiency at < 60% (59.4%).

conclusionsThe high prevalence of STIs among youth, even in those with no or one reported risk factor, may preclude the use of risk prediction tools for selective STI testing. At a cut-point of 19 one in six young people with STIs would be missed.

Indexed as

Chlamydia InfectionsGonorrheaHIV InfectionsSexually Transmitted DiseasesAdolescentChlamydia trachomatisFemaleHumansNeisseria gonorrhoeaePregnancyPrevalenceSexual BehaviorSexual PartnersYoung AdultAdolescentsRisk prediction toolScreeningSexually transmitted infections

Identifiers

PMID34879820
PMCPMC8653586
OpenAlexW4225874089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.